Lower sarcoplasmic reticulum Ca2+ threshold for triggering afterdepolarizations in diabetic rat hearts

Published:November 07, 2018DOI:


      Type 2 diabetes (T2D) increases arrhythmia risk through incompletely elucidated mechanisms. Ventricular arrhythmias could be initiated by delayed afterdepolarizations (DADs) resulting from elevated spontaneous sarcoplasmic reticulum (SR) Ca2+ release (SR Ca2+ leak).


      The purpose of this study was to test the role of DADs and SR Ca2+ leak in triggering arrhythmias in T2D hearts.


      We compared rats with late-onset T2D that display pancreatic and cardiac phenotypes similar to those in humans with T2D (HIP rats) and their nondiabetic littermates (wild type [WT]).


      HIP rats showed higher propensity for premature ventricular complexes and ventricular tachyarrhythmias, whereas HIP myocytes displayed more frequent DADs and had lower SR Ca2+ content than WT. However, the threshold SR Ca2+ at which depolarizing transient inward currents (Itis) are generated was also significantly decreased in HIP myocytes and was below the actual SR Ca2+ load, which explains the increased DAD incidence despite reduced Ca2+ in SR. In agreement with these findings, Ca2+ spark frequency was augmented in myocytes from HIP vs WT rats, which suggests activation of ryanodine receptors (RyRs) in HIP hearts. Indeed, RyR phosphorylation (by CaMKII and protein kinase A) and oxidation are enhanced in HIP hearts, whereas there is no RyR O-GlcNAcylation in either HIP or control hearts. CaMKII inhibition dissipated the difference in Ca2+ spark frequency between HIP and WT myocytes.


      The threshold SR Ca2+ for generating depolarizing Itis is lower in T2D because of RyR activation after hyperphosphorylation and oxidation, which favors the occurrence of DADs despite low SR Ca2+ loads.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Devereux R.B.
        • Roman M.J.
        • Paranicas M.
        • O'Grady M.J.
        • Lee E.T.
        • Welty T.K.
        • Fabsitz R.R.
        • Robbins D.
        • Rhoades E.R.
        • Howard B.V.
        Impact of diabetes on cardiac structure and function: the strong heart study.
        Circulation. 2000; 101: 2271-2276
        • Taegtmeyer H.
        • McNulty P.
        • Young M.E.
        Adaptation and maladaptation of the heart in diabetes: Part I: general concepts.
        Circulation. 2002; 105: 1727-1733
        • Bugger H.
        • Abel E.D.
        Molecular mechanisms of diabetic cardiomyopathy.
        Diabetologia. 2014; 57: 660-671
        • Jia G.
        • DeMarco V.G.
        • Sowers J.R.
        Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.
        Nat Rev Endocrinol. 2016; 12: 144-153
        • Ingelsson E.
        • Sundstrom J.
        • Arnlov J.
        • Zethelius B.
        • Lind L.
        Insulin resistance and risk of congestive heart failure.
        J Am Med Assoc. 2005; 294: 334-341
        • Masoudi F.A.
        • Inzucchi S.E.
        Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy.
        Am J Cardiol. 2007; 99: 113B-132B
        • Adeghate E.
        • Singh J.
        Structural changes in the myocardium during diabetes-induced cardiomyopathy.
        Heart Fail Rev. 2014; 19: 15-23
        • Balkau B.
        • Jouven X.
        • Ducimetière P.
        • Eschwège E.
        Diabetes as a risk factor for sudden death.
        Lancet. 1999; 354: 1968-1969
        • Chen-Scarabelli C.
        • Scarabelli T.M.
        Suboptimal glycemic control, independently of QT interval duration, is associated with increased risk of ventricular arrhythmias in a high-risk population.
        Pacing Clin Electrophysiol. 2006; 29: 9-14
        • Movahed M.R.
        • Hashemzadeh M.
        • Jamal M.
        Increased prevalence of ventricular fibrillation in patients with type 2 diabetes mellitus.
        Heart Vessels. 2007; 22: 251-253
        • Koektuerk B.
        • Aksoy M.
        • Horlitz M.
        • Bozdag-Turan I.
        • Turan R.G.
        Role of diabetes in heart rhythm disorders.
        World J Diabetes. 2016; 7: 45-49
        • Liu M.B.
        • de Lange E.
        • Garfinkel A.
        • Weiss J.N.
        • Qu Z.
        Delayed afterdepolarizations generate both triggers and a vulnerable substrate promoting reentry in cardiac tissue.
        Heart Rhythm. 2015; 12: 2115-2124
        • Despa S.
        • Sharma S.
        • Harris T.R.
        • Dong H.
        • Li N.
        • Chiamvimonvat N.
        • Taegtmeyer H.
        • Margulies K.B.
        • Hammock B.D.
        • Despa F.
        Cardioprotection by controlling hyperamylinemia in a "humanized" diabetic rat model.
        J Am Heart Assoc. 2014; 3: e001015
        • Guglielmino K.
        • Jackson K.
        • Harris T.R.
        • et al.
        Pharmacological inhibition of soluble epoxide hydrolase provides cardioprotection in hyperglycemic rats.
        Am J Physiol Heart Circ Physiol. 2012; 303: H853-H862
        • Pereira L.
        • Matthes J.
        • Schuster I.
        • Valdivia H.H.
        • Herzig S.
        • Richard S.
        • Gómez A.M.
        Mechanisms of [Ca2+]i transient decrease in cardiomyopathy of db/db type 2 diabetic mice.
        Diabetes. 2006; 55: 608-615
        • Belke D.D.
        • Swanson E.A.
        • Dillmann W.H.
        Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart.
        Diabetes. 2004; 53: 3201-3208
        • Stølen T.O.
        • Høydal M.A.
        • Kemi O.J.
        • Catalucci D.
        • Ceci M.
        • Aasum E.
        • Larsen T.
        • Rolim N.
        • Condorelli G.
        • Smith G.L.
        • Wisløff U.
        Interval training normalizes cardiomyocyte function, diastolic Ca2+ control, and SR Ca2+ release synchronicity in a mouse model of diabetic cardiomyopathy.
        Circ Res. 2009; 105: 527-536
        • Butler A.E.
        • Jang J.
        • Gurlo T.
        • Carty M.D.
        • Soeller W.C.
        • Butler P.C.
        Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes.
        Diabetes. 2004; 53: 1509-1516
        • Boquist L.
        • Hellman B.
        • Lernmark A.
        • Täljedal I.B.
        Influence of the mutation "diabetes" on insulin release and islet morphology in mice of different genetic backgrounds.
        J Cell Biol. 1974; 62: 77-89
        • Matveyenko A.V.
        • Butler P.C.
        β-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type-2 diabetes.
        Diabetes. 2006; 55: 2106-2114
        • Despa S.
        • Margulies K.B.
        • Chen L.
        • Knowlton A.A.
        • Havel P.J.
        • Taegtmeyer H.
        • Bers D.M.
        • Despa F.
        Hyperamylinemia contributes to heart dysfunction in obesity and diabetes, a study in humans and rats.
        Circ Res. 2012; 110: 598-608
        • Erickson J.R.
        • Pereira L.
        • Wang L.
        • Han G.
        • Ferguson A.
        • Dao K.
        • Copeland R.J.
        • Despa F.
        • Hart G.W.
        • Ripplinger C.M.
        • Bers D.M.
        Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation.
        Nature. 2013; 502: 372-376
        • Westermark P.
        • Andersson A.
        • Westermark G.T.
        Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
        Physiol Rev. 2011; 91: 795-826
        • Pogwizd S.M.
        • Schlotthauer K.
        • Li L.
        • Yuan W.
        • Bers D.M.
        Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness.
        Circ Res. 2001; 88: 1159-1167
        • Shannon T.R.
        • Ginsburg K.S.
        • Bers D.M.
        Quantitative assessment of the SR Ca2+ leak-load relationship.
        Circ Res. 2002; 91: 594-600
        • Bovo E.
        • Lipsius S.L.
        • Zima A.V.
        Reactive oxygen species contribute to the development of arrhythmogenic Ca2+ waves during β-adrenergic receptor stimulation in rabbit cardiomyocytes.
        J Physiol. 2012; 590: 3291-3304
        • Bers D.M.
        Excitation-Contraction Coupling and Cardiac Contractile Force.
        2nd ed. Kluwer Academic, 2001
        • Banerjee P.S.
        • Lagerlöf O.
        • Hart G.W.
        Roles of O-GlcNAc in chronic diseases of aging.
        Mol Aspects Med. 2016; 51: 1-15
        • Erickson J.R.
        Mechanisms of CaMKII Activation in the heart.
        Front Pharmacol. 2014; 5: 59
        • Lambert R.
        • Srodulski S.
        • Peng X.
        • Margulies K.B.
        • Despa F.
        • Despa S.
        Intracellular Na+ concentration ([Na+]i) is elevated in diabetic hearts due to enhanced Na+-glucose cotransport.
        J Am Heart Assoc. 2015; 4: e002183
        • Sommese L.
        • Valverde C.A.
        • Blanco P.
        • Castro M.C.
        • Rueda O.V.
        • Kaetzel M.
        • Dedman J.
        • Anderson M.E.
        • Mattiazzi A.
        • Palomeque J.
        Ryanodine receptor phosphorylation by CaMKII promotes spontaneous Ca2+ release events in a rodent model of early stage diabetes: the arrhythmogenic substrate.
        Int J Cardiol. 2016; 202: 394-406
        • Liu M.
        • Hoskins A.
        • Verma N.
        • Bers D.M.
        • Despa S.
        • Despa F.
        Amylin and diabetic cardiomyopathy: amylin-induced sarcolemmal Ca2+ leak is independent of diabetic remodeling of myocardium.
        Biochim Biophys Acta Mol Basis Dis. 2018; 1864: 1923-1930
        • Maxwell J.T.
        • Domeier T.L.
        • Blatter L.A.
        Dantrolene prevents arrhythmogenic Ca2+ release in heart failure.
        Am J Physiol Heart Circ Physiol. 2012; 302: H953-H963
        • Priori S.G.
        • Chen S.R.
        Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis.
        Circ Res. 2011; 108: 871-883
        • Kashimura T.
        • Briston S.J.
        • Trafford A.W.
        • Napolitano C.
        • Priori S.G.
        • Eisner D.A.
        • Venetucci L.A.
        In the RyR2(R4496C) mouse model of CPVT, β-adrenergic stimulation induces Ca waves by increasing SR Ca content and not by decreasing the threshold for Ca waves.
        Circ Res. 2010; 107: 1483-1489